Evan M. Cale, Ph.D. - Related publications

2011 Harvard University, Cambridge, MA, United States 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
27 most relevant papers in past 60 days:
Year Citation  Score
2022 Koerber N, Priller A, Yazici S, Bauer T, Cheng CC, Mijočević H, Wintersteller H, Jeske S, Vogel E, Feuerherd M, Tinnefeld K, Winter C, Ruland J, Gerhard M, Haller B, et al. Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents. Nature Communications. 13: 153. PMID 35013191 DOI: 10.1038/s41467-021-27649-y   
2022 Swain SK, Gadnayak A, Mohanty JN, Sarangi R, Das J. Does enterovirus 71 urge for effective vaccine control strategies? Challenges and current opinion. Reviews in Medical Virology. e2322. PMID 34997684 DOI: 10.1002/rmv.2322   
2022 Ghosh P, Bhattacharya M, Patra P, Sharma G, Patra BC, Lee SS, Sharma AR, Chakraborty C. Evaluation and Designing of Epitopic-Peptide Vaccine Against Using M-Polyprotein Target Sequences. International Journal of Peptide Research and Therapeutics. 28: 5. PMID 34867129 DOI: 10.1007/s10989-021-10322-9   
2022 Lalzampuia H, Elango S, Biswal JK, Krishnaswamy N, Selvan RPT, Saravanan P, Mahadappa P, V Umapathi, Reddy GR, Bhanuprakash V, Sanyal A, Dechamma HJ. Infection and protection responses of deletion mutants of non-structural proteins of foot-and-mouth disease virus serotype Asia1 in guinea pigs. Applied Microbiology and Biotechnology. 106: 273-286. PMID 34889988 DOI: 10.1007/s00253-021-11692-2   
2022 Lynch KL, Zhou S, Kaul R, Walker R, Wu AH. Evaluation of neutralizing antibodies against SARS-CoV-2 variants after infection and vaccination using a multiplexed surrogate virus neutralization test. Clinical Chemistry. PMID 35018416 DOI: 10.1093/clinchem/hvab283   
2022 Tay MZ, Rouers A, Fong SW, Goh YS, Chan YH, Chang ZW, Xu W, Tan CW, Chia WN, Torres-Ruesta A, Amrun SN, Huang Y, Hor PX, Loh CY, Yeo NK, et al. Decreased memory B cells frequencies in COVID-19 Delta variant vaccine breakthrough infection. Embo Molecular Medicine. e15227. PMID 34994081 DOI: 10.15252/emmm.202115227   
2022 Haque A, Pant AB. Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy. Journal of Autoimmunity. 127: 102792. PMID 34995958 DOI: 10.1016/j.jaut.2021.102792   
2022 Bliss CM, Freyn AW, Caniels TG, Leyva-Grado VH, Nachbagauer R, Sun W, Tan GS, Gillespie VL, McMahon M, Krammer F, Hill AV, Palese P, Coughlan L. A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 34999208 DOI: 10.1016/j.ymthe.2022.01.011   
2022 Kim Y, Zheng X, Eschke K, Chaudhry MZ, Bertoglio F, Tomić A, Krmpotić A, Hoffmann M, Bar-On Y, Boehme J, Bruder D, Ebensen T, Brunotte L, Ludwig S, Messerle M, et al. MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination. Cellular & Molecular Immunology. PMID 34992275 DOI: 10.1038/s41423-021-00814-5   
2022 Sankaradoss A, Jagtap S, Nazir J, Moula SE, Modak A, Fialho J, Iyer M, Shastri JS, Dias M, Gadepalli R, Aggarwal A, Vedpathak M, Agrawal S, Pandit A, Nisheetha A, et al. Immune profile and responses of a novel Dengue DNA vaccine encoding EDIII-NS1 consensus design based on Indo-African sequences. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 34999210 DOI: 10.1016/j.ymthe.2022.01.013   
2022 Bhattacharya M, Sharma AR, Ghosh P, Patra P, Patra BC, Lee SS, Chakraborty C. Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach. Molecular Biotechnology. PMID 34981440 DOI: 10.1007/s12033-021-00432-6   
2022 Li X, Chan JM, Lam B, Lung DC, Lung KC, Chow CK, Tam T, Chiu KH, Hung LL, Hung IF, Cheng VC, To KK, Yuen KY. COVID-19 mRNA vaccines delay the onset of breakthrough infections with less radiographic abnormalities. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34984442 DOI: 10.1093/cid/ciab1062   
2022 Shin M, Kim K, Lee HJ, Lee R, Jung YJ, Park J, Hahn TW. Zika virus baculovirus-expressed envelope protein elicited humoral and cellular immunity in immunocompetent mice. Scientific Reports. 12: 660. PMID 35027643 DOI: 10.1038/s41598-021-04713-7   
2022 Hu Z, Huang Y, Zhao J, Hu J, Hu S, Liu X. Expression and characterization of a recombinant broadly-reactive monoclonal antibody against group 1 and 2 influenza viruses. Protein Expression and Purification. 192: 106046. PMID 35007721 DOI: 10.1016/j.pep.2022.106046   
2022 Servellita V, Morris MK, Sotomayor-Gonzalez A, Gliwa AS, Torres E, Brazer N, Zhou A, Hernandez KT, Sankaran M, Wang B, Wong D, Wang C, Zhang Y, Reyes KR, Glasner D, et al. Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California. Nature Microbiology. PMID 35013591 DOI: 10.1038/s41564-021-01041-4   
2022 Zhao X, Chen D, Li X, Griffith L, Chang J, An P, Guo JT. Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development. Journal of Molecular Biology. 167438. PMID 34990653 DOI: 10.1016/j.jmb.2021.167438   
2022 Wang N, Zhai X, Li X, Wang Y, He WT, Jiang Z, Veit M, Su S. Attenuation of Getah virus by a single amino acid substitution at residue 253 of the E2 protein that might be part of a new heparan sulfate binding site on alphaviruses. Journal of Virology. jvi0175121. PMID 34986000 DOI: 10.1128/jvi.01751-21   
2022 Zhao H, Han Q, Yang A, Wang Y, Wang G, Lin A, Wang X, Yin C, Zhang J. CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV. International Journal of Biological Sciences. 18: 154-165. PMID 34975324 DOI: 10.7150/ijbs.62424   
2022 Sievers BL, Chakraborty S, Xue Y, Gelbart T, Gonzalez JC, Cassidy AG, Golan Y, Prahl M, Gaw SL, Arunachalam PS, Blish CA, Boyd SD, Davis MM, Jagannathan P, Nadeau KC, et al. Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses. Science Translational Medicine. eabn7842. PMID 35025672 DOI: 10.1126/scitranslmed.abn7842   
2022 Antanasijevic A, Bowman CA, Kirchdoerfer RN, Cottrell CA, Ozorowski G, Upadhyay AA, Cirelli KM, Carnathan DG, Enemuo CA, Sewall LM, Nogal B, Zhao F, Groschel B, Schief WR, Sok D, et al. From structure to sequence: Antibody discovery using cryoEM. Science Advances. 8: eabk2039. PMID 35044813 DOI: 10.1126/sciadv.abk2039   
2022 Li T, Cui Z, Jia Y, Liang Z, Nie J, Zhang L, Wang M, Li Q, Wu J, Xu N, Liu S, Li X, An Y, Han P, Zhang M, et al. Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift. Journal of Medical Virology. PMID 35032057 DOI: 10.1002/jmv.27596   
2022 Cheng ZJ, Li B, Zhan Z, Zhao Z, Xue M, Zheng P, Lyu J, Hu C, He J, Chen R, Sun B. Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy. Clinical Reviews in Allergy & Immunology. PMID 35031959 DOI: 10.1007/s12016-021-08912-y   
2022 Gupta SL, Jaiswal RK. Neutralizing antibody: a savior in the Covid-19 disease. Molecular Biology Reports. PMID 34988889 DOI: 10.1007/s11033-021-07020-6   
2022 Eyre DW, Taylor D, Purver M, Chapman D, Fowler T, Pouwels KB, Walker AS, Peto TEA. Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants. The New England Journal of Medicine. PMID 34986294 DOI: 10.1056/NEJMoa2116597   
2022 Qiao Y, Jin S, Nie J, Chang Y, Wang B, Guan S, Li Q, Shi Y, Kong W, Shan Y. Hemagglutinin-based DNA vaccines containing trimeric self-assembling nanoparticles confer protection against influenza. Journal of Leukocyte Biology. PMID 35040188 DOI: 10.1002/JLB.6A1021-535R   
2022 Liu L, Li Z, Zhou J, Liu J, Li X, Huang W, Xiao N, Wang D. Homologous PB1 gene promotes the replication efficiency of avian influenza H7N4 candidate vaccine virus. Influenza and Other Respiratory Viruses. PMID 35037399 DOI: 10.1111/irv.12954   
2022 Huang KA, Zhou D, Tan TK, Chen C, Duyvesteyn HME, Zhao Y, Ginn HM, Qin L, Rijal P, Schimanski L, Donat R, Harding A, Gilbert-Jaramillo J, James W, Tree JA, et al. Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2. Theranostics. 12: 1-17. PMID 34987630 DOI: 10.7150/thno.65563